Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Jan 29 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ghmm who wrote (1454)	10/6/2007 9:16:08 PM
From: rkrw	Read Replies (1) of 1494

I follow them more out of curiosity. One problem is any stroke program which succeeds is going to come out of LF, so you won't see a valuation premium (more like a valuation discount) without real data. Risk reward on something like this is bound to be enormous. ntii has been chronically underfunded and recapping was a good idea, but they've bungled it terribly to the detriment of existing shareholders. I don't think the funding is going as well as they had hoped. They just added a second underwriter, had to do a bridge loan and it seems to be dragging on. It'll be interesting to see how close to that $40M they aim to raise, they're already down $6M in debt they need to repay.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next